$Equillium (EQ.US)$
Received delisting notice Dec 13
Have until June 10 to regain
Can regain with a RS
Price currently .80 --might see a pump to regain compliance and avoid a reverse split.

$Equillium (EQ.US)$
Phase 2 Clinical Success: New UC Treatment Achieves 23.3% Remission Rate, Rivaling Industry Standard

$Equillium (EQ.US)$
Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis
Thursday, 6th February at 8:00 am
Itolizumab demonstrated clinical efficacy after 12 weeks of treatment, achieving a clinical remission rate of 23.3% compared to 20.0% for adalimumab and 10.0% for placebo
Itolizumab achieved key secondary endpoint of endoscopic remission of 16.7% compared to 16.7% for adalimumab and 6.7% for placebo
Itolizuma...

$Equillium (EQ.US)$ Reuters· just
Equillium Announces Positive Data From Phase 2 Study Evaluating Itolizumab in Patients With Moderate to Severe Ulcerative Colitis

$Equillium (EQ.US)$
is this stock still even alive

$Equillium (EQ.US)$ so pump to 1.2 next week?  ok

Good stock?
$Equillium (EQ.US)$